MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma

NCT00298467 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

45

Enrollment

INDUSTRY

Sponsor class

Stopped sponsor decision

Conditions

Lymphoma, Large-Cell

Interventions

DRUG: MDX-060

Sponsor

Bristol-Myers Squibb